Press Resease

Global Remdesivir Market - by Dosage (2.5mg, 5mg, 100mg, 200mg), by Patient (Adult, Pediatric, and Geriatric), by Application (Ebola, SARS-COV, MERS-COV, COVID-19), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Published Date: 04-Aug-2020 Category: Pharmaceutical Report Format : PDF Pages: 135 Report Code: ZMR-5358 Status : Published

Occurrences of pandemics like COVID-19, Ebola, and growing prevalence of viral diseases will act as major driving factors in the growth of global Remdesivir market.

Description

The report covers forecast and analysis for the Remdesivir market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Remdesivir market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Remdesivir market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the Remdesivir market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Dosage, Patient, Application, End user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Global Remdesivir Market

The report provides company market share analysis in order to give a broader overview of the key players in the Remdesivir market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the Remdesivir market on global and regional basis.

The report segments global Remdesivir market as follows:

Global Remdesivir Market: Dosage

  • 2.5mg
  • 5mg
  • 100mg
  • 200mg

Global Remdesivir Market: By Patient

  • Adult
  • Pediatric
  • Geriatric

Global Remdesivir Market: By Application

  • Ebola
  • SARS-COV
  • MERS-COV
  • COVID-19
    • Invasive mechanical ventilation
    • Non-Invasive mechanical ventilation

Global Remdesivir Market: By End user

  • Hospitals
  • Clinics
  • Pharmacy & Drug Stores
  • Online Pharmacies

Global Remdesivir Market: By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Remdesivir Market, 2016 - 2026, (USD Billion)
    • 2.2. Remdesivir Market: Snapshot
  • Chapter 3. Global Remdesivir Market – Industry Analysis
    • 3.1. Remdesivir Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Outbreaks of pandemics like COVID-19, Ebula
      • 3.2.2. Growing prevalence of viral diseases
    • 3.3. Restraints
      • 3.3.1. High cost of Remdesivir
    • 3.4. Opportunity
      • 3.4.1. High investment in research and development to investigate for further uses of Remdesivir
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Dosage segment
      • 3.6.2. Market attractiveness analysis by Patient segment
      • 3.6.3. Market attractiveness analysis by Application segment
      • 3.6.4. Market attractiveness analysis by End user segment
      • 3.6.5. Market attractiveness analysis by regional segment
  • Chapter 4. Global Remdesivir Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Remdesivir market: company market share analysis, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Dosage type launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Remdesivir Market – Dosage Type Segment Analysis
    • 5.1. Global Remdesivir market overview: by Dosage type
      • 5.1.1. Global Remdesivir market revenue share, by Dosage type, 2019 and 2026
      • 5.2. 2.5mg
      • 5.2.1. Global Remdesivir market by 2.5mg, 2016-2026 (USD Billion)
    • 5.3. 5mg
      • 5.3.1. Global Remdesivir market by 5mg, 2016-2026 (USD Billion)
    • 5.4. 100mg
      • 5.4.1. Global Remdesivir market by 100mg, 2016-2026 (USD Billion)
    • 5.5. 200mg
      • 5.5.1. Global Remdesivir market by 200mg, 2016-2026 (USD Billion)
  • Chapter 6. Global Remdesivir Market – Patient Segment Analysis
    • 6.1. Global Remdesivir market overview: by Patient
      • 6.1.1. Global Remdesivir market revenue share, by Patient, 2019 and 2026
    • 6.2. Growth Factors
      • 6.2.1. Global Remdesivir market by Growth Factors, 2016-2026 (USD Billion)
    • 6.3. Adult
      • 6.3.1. Global Remdesivir market by Adult, 2016-2026 (USD Billion)
    • 6.4. Pediatric
      • 6.4.1. Global Remdesivir market by Pediatric, 2016-2026 (USD Billion)
    • 6.5. Geriatric
      • 6.5.1. Global Remdesivir market by Geriatric, 2016-2026 (USD Billion)
  • Chapter 7. Global Remdesivir Market – Application Segment Analysis
    • 7.1. Global Remdesivir market overview: by Application
      • 7.1.1. Global Remdesivir market revenue share, by Application, 2019 and 2026
    • 7.2. Growth Factors
      • 7.2.1. Global Remdesivir market by Growth Factors, 2016-2026 (USD Billion)
    • 7.3. Ebula
      • 7.3.1. Global Remdesivir market by Ebula, 2016-2026 (USD Billion)
    • 7.4. SARS-COV
      • 7.4.1. Global Remdesivir market by SARS-COV, 2016-2026 (USD Billion)
    • 7.5. MERS-COV
      • 7.5.1. Global Remdesivir market by MERS-COV, 2016-2026 (USD Billion)
    • 7.6. COVID-19
      • 7.6.1. Global Remdesivir market by COVID-19, 2016-2026 (USD Billion)
  • Chapter 8. Global Remdesivir Market – End user Segment Analysis
    • 8.1. Global Remdesivir market overview: by End user
      • 8.1.1. Global Remdesivir market revenue share, by End user, 2019 and 2026
    • 8.2. Hospitals
      • 8.2.1. Global Remdesivir market by Hospitals, 2016-2026 (USD Billion)
    • 8.3. Clinics
      • 8.3.1. Global Remdesivir market by Clinics, 2016-2026 (USD Billion)
    • 8.4. Pharmacy & Drug Stores
      • 8.4.1. Global Remdesivir market by Pharmacy & Drug Stores, 2016-2026 (USD Billion)
    • 8.5. Online Pharmacies
      • 8.5.1. Global Remdesivir market by Online Pharmacies, 2016-2026 (USD Billion)
  • Chapter 9. Global Remdesivir Market - Regional Analysis
    • 9.1. Global Remdesivir market overview: by region
      • 9.1.1. Global Remdesivir market revenue share, by region, 2019 and 2026
    • 9.2. North America
      • 9.2.1. North America Remdesivir market, by country, 2016-2026 (USD Billion)
      • 9.2.2. North America Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
      • 9.2.3. North America Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
      • 9.2.4. North America Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
      • 9.2.5. North America Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.2.6.2. The U.S. Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.2.6.3. The U.S. Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.2.6.4. The U.S. Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.2.7. Rest of North America
        • 9.2.7.1. Rest of North America Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.2.7.2. Rest of North America Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.2.7.3. Rest of North America Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.2.7.4. Rest of North America Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe Remdesivir market, by country, 2016-2026 (USD Billion)
      • 9.3.2. Europe Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
      • 9.3.3. Europe Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
      • 9.3.4. Europe Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
      • 9.3.5. Europe Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
        • 9.3.6. U.K.
          • 9.3.6.1. U.K. Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
          • 9.3.6.2. U.K. Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
          • 9.3.6.3. U.K. Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
          • 9.3.6.4. U.K. Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.3.7. France
        • 9.3.7.1. France Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.3.7.2. France Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.3.7.3. France Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.3.7.4. France Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.3.8. Germany
        • 9.3.8.1. Germany Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.3.8.2. Germany Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.3.8.3. Germany Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.3.8.4. Germany Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.3.9.2. Rest of Europe Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.3.9.3. Rest of Europe Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.3.9.4. Rest of Europe Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Remdesivir market, by country, 2016-2026 (USD Billion)
      • 9.4.2. Asia Pacific Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
      • 9.4.3. Asia Pacific Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
      • 9.4.4. Asia Pacific Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
      • 9.4.5. Asia Pacific Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.4.6. China
        • 9.4.6.1. China Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.4.6.2. China Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.4.6.3. China Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.4.6.4. China Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.4.7. Japan
        • 9.4.7.1. Japan Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.4.7.2. Japan Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.4.7.3. Japan Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.4.7.4. Japan Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.4.8. India
        • 9.4.8.1. India Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.4.8.2. India Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.4.8.3. India Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.4.8.4. India Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.4.9.2. Rest of Asia Pacific Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.4.9.3. Rest of Asia Pacific Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.4.9.4. Rest of Asia Pacific Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America Remdesivir market, by country, 2016-2026 (USD Billion)
      • 9.5.2. Latin America Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
      • 9.5.3. Latin America Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
      • 9.5.4. Latin America Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
      • 9.5.5. Latin America Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.5.6.2. Brazil Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.5.6.3. Brazil Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.5.6.4. Brazil Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
        • 9.5.7.2. Rest of Latin America Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
        • 9.5.7.3. Rest of Latin America Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
        • 9.5.7.4. Rest of Latin America Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
    • 9.6. Middle East & Africa
      • 9.6.1. Middle East & Africa Remdesivir market, 2016-2026 (USD Billion)
      • 9.6.2. Middle East & Africa Remdesivir market revenue, by Dosage type, 2016-2026 (USD Billion)
      • 9.6.3. Middle East & Africa Remdesivir market revenue, by Patient, 2016-2026 (USD Billion)
      • 9.6.4. Middle East & Africa Remdesivir market revenue, by Application, 2016-2026 (USD Billion)
      • 9.6.5. Middle East & Africa Remdesivir market revenue, by End user, 2016-2026 (USD Billion)
  • Chapter 10. Company Profiles
    • 10.1. Gilead Sciences.
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. Bright Gene
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. Hainan Haiyao.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. Kelun Pharma
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Hunan Warrant Pharmaceutical
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Hetero
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Cipla
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. Jubilant Lifesciences
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments

Methodology


Frequently Asked Questions

The report also includes detailed profiles of key players such Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Hetero, Cipla, Jubilant Lifesciences among others.

North America will be the leading region during the forecast period. Increasing cases of covid-19, High prevalence of diseases, easy availability, and presence of leading market players will boost the market growth in this region. Europe will be the second largest market.

Occurrences of pandemics like COVID-19, Ebola, and growing prevalence of viral diseases will act as major driving factors in the growth of global Remdesivir market. High investment in research and development to investigate for further uses of Remdesivir will act as an opportunity for the market players in the Remdesivir market.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social